Published in J Clin Microbiol on October 01, 2000
Routine molecular identification of enterococci by gene-specific PCR and 16S ribosomal DNA sequencing. J Clin Microbiol (2001) 0.94
Enterococcus faecium-related outbreak with molecular evidence of transmission from pigs to humans. J Clin Microbiol (2002) 0.89
Laboratory contamination of specimens with quality control strains of vancomycin-resistant enterococci in Ontario. J Clin Microbiol (2002) 0.87
Prevalence of vancomycin-resistant enterococcus in prenatal screening cultures. J Clin Microbiol (2004) 0.75
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
The life and times of the Enterococcus. Clin Microbiol Rev (1990) 16.58
Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol (1989) 13.84
Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol (1990) 13.66
Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol (1995) 12.98
Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis (1999) 10.30
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39
Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother (1993) 6.28
Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis (1998) 4.84
Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis (1991) 4.82
Species identities of enterococci isolated from clinical specimens. J Clin Microbiol (1990) 4.54
Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep (1995) 4.19
Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med (1995) 3.77
VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother (1997) 2.50
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol (1992) 2.23
Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis (1997) 1.95
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother (1999) 1.95
Acidification of methyl-alpha-D-glucopyranoside: a useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and from Enterococcus faecalis. J Clin Microbiol (1996) 1.72
DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J Clin Microbiol (1999) 1.71
Intrahospital spread of a single gentamicin-resistant, beta-lactamase-producing strain of Enterococcus faecalis in Argentina. Antimicrob Agents Chemother (1992) 1.63
Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype) J Clin Microbiol (1997) 1.63
High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patients. Arch Intern Med (1987) 1.49
Enterococci and vancomycin resistance. Clin Infect Dis (1998) 1.38
Practical approach to the identification of clinically relevant Enterococcus species. Diagn Microbiol Infect Dis (1999) 1.20
Vancomycin-resistant enterococci. Mechanism and clinical relevance. Infect Dis Clin North Am (1997) 1.18
Screening of stool samples for identification of vancomycin-resistant Enterococcus isolates should include the methyl-alpha-D-glucopyranoside test to differentiate nonmotile Enterococcus gallinarum from E. faecium. J Clin Microbiol (1998) 1.11
Use of tests for acidification of methyl-alpha-D-glucopyranoside and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera. J Clin Microbiol (1998) 1.10
Identification of clinically isolated vancomycin-resistant enterococci: comparison of API and BBL Crystal systems. J Med Microbiol (1999) 0.98
Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures. Infect Dis Clin North Am (1997) 0.98
Bacteremia due to motile Enterococcus species: clinical features and outcomes. Clin Infect Dis (1999) 0.97
Comparison of phenotypic methods to identify enterococci intrinsically resistant to vancomycin (VanC VRE). Diagn Microbiol Infect Dis (2000) 0.95
Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci. J Clin Microbiol (1998) 0.93
Comparison of simple and rapid methods for identifying enterococci intrinsically resistant to vancomycin. J Clin Microbiol (1999) 0.90
Colonization and microbiology of the motile enterococci in a patient population. Diagn Microbiol Infect Dis (1998) 0.89
The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control (1995) 0.88
Enterococcal bacteremia in a tertiary care centre in Winnipeg. Can J Infect Dis (1999) 0.79
STUDIES BASED ON A MALIGNANT TUMOR OF THE RABBIT : III. INTRATESTICULAR TRANSPLANTATION AND CLINICAL COURSE OF THE DISEASE. J Exp Med (1923) 11.87
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science (1993) 10.09
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
ORGAN WEIGHTS OF NORMAL RABBITS. J Exp Med (1925) 9.95
Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med (1996) 8.41
Emergence of vancomycin-resistant enterococci in New York City. Lancet (1993) 7.37
THE INFLUENCE OF LIGHT ON THE REACTION TO INFECTION IN EXPERIMENTAL SYPHILIS. J Exp Med (1927) 7.12
ORGAN WEIGHTS OF NORMAL RABBITS : SECOND PAPER. J Exp Med (1926) 6.34
EXPERIMENTAL SYPHILIS IN THE RABBIT : I. PRIMARY INFECTION IN THE TESTICLE. J Exp Med (1920) 6.18
GROWTH AND PERSISTENCE OF FILTERABLE VIRUSES IN A TRANSPLANTABLE RABBIT NEOPLASM. J Exp Med (1925) 5.40
STUDIES BASED ON A MALIGNANT TUMOR OF THE RABBIT : I. THE SPONTANEOUS TUMOR AND ASSOCIATED ABNORMALITIES. J Exp Med (1923) 4.68
EFFECTS OF OBSCURE LESIONS ON ORGAN WEIGHTS OF APPARENTLY NORMAL RABBITS. J Exp Med (1925) 4.31
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med (2000) 4.20
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis (2005) 3.54
A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ (1998) 3.46
The validity of a sore throat score in family practice. CMAJ (2000) 3.34
EXPERIMENTAL SYPHILIS IN THE RABBIT : II. PRIMARY INFECTION IN THE SCROTUM. PART 1. REACTION TO INFECTION. J Exp Med (1920) 3.33
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 3.19
The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ (2001) 2.99
EXPERIMENTAL SYPHILIS IN THE RABBIT : IV. CUTANEOUS SYPHILIS. PART 1. AFFECTIONS OF THE SKIN AND APPENDAGES. J Exp Med (1920) 2.87
STUDIES ON THE ETIOLOGY OF RABBIT POX : II. CLINICAL CHARACTERISTICS OF THE EXPERIMENTALLY INDUCED DISEASE. J Exp Med (1936) 2.83
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
RELATION BETWEEN ORGAN WEIGHTS AND OBSCURE LESIONS IN APPARENTLY NORMAL RABBITS : SECOND PAPER. J Exp Med (1926) 2.67
Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med (1997) 2.60
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol (1990) 2.53
Genetic locus for streptolysin S production by group A streptococcus. Infect Immun (2000) 2.52
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
STUDIES BASED ON A MALIGNANT TUMOR OF THE RABBIT : VI. VARIATIONS IN GROWTH AND MALIGNANCY OF TRANSPLANTED TUMORS. PART 1. RESUTLTS OF TRANSPLANTATION FOR THE FIRST TWENTY GENERATIONS. J Exp Med (1924) 2.28
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun (2000) 2.24
Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis. J Clin Microbiol (1990) 2.22
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance. Antimicrob Agents Chemother (2000) 2.22
HEREDITARY VARIATIONS IN THE BLOOD CYTOLOGY OF NORMAL RABBITS. Science (1934) 2.14
Streptococcal toxic shock syndrome in dogs. J Am Vet Med Assoc (1996) 2.11
Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis (1987) 2.10
Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med (1999) 2.10
Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women. Diagn Microbiol Infect Dis (1994) 2.09
Problems with rapid agglutination methods for identification of Staphylococcus aureus when Staphylococcus saprophyticus is being tested. J Clin Microbiol (1988) 2.09
EFFECTS OF SPONTANEOUS DISEASE ON ORGAN WEIGHTS OF RABBITS. J Exp Med (1926) 2.09
Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis (1993) 2.07
Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother (1999) 2.01
The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc (1996) 1.97
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med (1999) 1.92
HEREDITARY ACHONDROPLASIA IN THE RABBIT : I. PHYSICAL APPEARANCE AND GENERAL FEATURES. J Exp Med (1945) 1.92
Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med (2006) 1.91
Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics (2000) 1.91
A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother (2000) 1.89
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis (1995) 1.88
Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics (1999) 1.85
Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. Clin Infect Dis (1998) 1.83
OBSERVATIONS ON THE BLOOD CYTOLOGY IN EXPERIMENTAL SYPHILIS : I. THE PERIOD OF DISEASE ACTIVITY. J Exp Med (1934) 1.82
Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method. J Clin Microbiol (1998) 1.75
Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network. Antimicrob Agents Chemother (1996) 1.74
Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med (2001) 1.70
Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol (2006) 1.69
Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group. Antimicrob Agents Chemother (1994) 1.69
STUDIES ON THE BLOOD CYTOLOGY OF THE RABBIT : VIII. THE BLOOD OF NORMAL RABBITS AS AN INDEX OF THEIR RESISTANCE TO A TRANSPLANTABLE NEOPLASM. J Exp Med (1931) 1.68
Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation (1999) 1.67
Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis. J Clin Microbiol (1992) 1.67
Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med (1999) 1.66
STUDIES BASED ON A MALIGNANT TUMOR OF THE RABBIT : V. METASTASES. PART 3. FACTORS THAT INFLUENCE OCCURRENCE AND DISTRIBUTION. J Exp Med (1923) 1.62
Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus. J Clin Microbiol (1992) 1.62
Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Antimicrob Agents Chemother (1989) 1.61
Species identification of enterococci via intergenic ribosomal PCR. J Clin Microbiol (1997) 1.61
Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1990) 1.59
Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. J Infect Dis (1999) 1.57
THE OCCURRENCE AND TREND OF SPONTANEOUS VARIATIONS IN ORGAN WEIGHTS OF NORMAL RABBITS. J Exp Med (1926) 1.57
Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992-2000. Clin Infect Dis (2005) 1.54
SUPERINFECTION IN EXPERIMENTAL SYPHILIS FOLLOWING THE ADMINISTRATION OF SUBCURATIVE DOSES OF ARSPHENAMINE OR NEOARSPHENAMINE. J Exp Med (1921) 1.54
EXPERIMENTAL SYPHILIS IN THE RABBIT : VI. AFFECTIONS OF BONE, CARTILAGE, TENDONS, AND SYNOVIAL MEMBRANES. PART 1. LESIONS OF THE SKELETAL SYSTEM. J Exp Med (1921) 1.53